CENNA BIOSCIENCES INC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | SAN DIEGO, California |
| Industry | unknown |
| Stage | unknown |
| Website | cennabiosciences.com |
Nubytide, a peptide therapeutic that reduces amyloid-beta production for Alzheimer's prevention and treatment. Built for licensing and clinical co-development. Positions as a more affordable, easier-to-administer alternative to anti-amyloid mAbs.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.7M | undisclosed |
Detected tech stack
Google Analytics, Google Tag Manager, DoubleClick Floodlight, Hostinger, Hostinger CDN, Hostinger Website Builder, Vue.js, WebsiteBuilder, WordPress, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | cennabiosciences.com, read 2026-05-02 |
| Description | self-reported | cennabiosciences.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.